NewsFri Apr 25, 2003 - 12:15 pm EST
DEPO-PROVERA LEADS TO 100 TIMES GREATER HERPES SUSCEPTABILITY
HAMILTON, ON, April 25, 2003 (LifeSiteNews.com) - Researchers at McMaster University have found that the abortifacient injectable birth-control drug Depo-Provera caused mice to be 100 times more susceptible to infection with herpes simplex virus type 2 (HSV-2). The study, published in the current issue of the Journal of Virology (2003;77:4558-4565), also found that the mice injected with the drug had a significantly weaker immune response when exposed to the virus. While spokesman for Pfizer, the pharmaceutical which manufactures Depo-Provera, were quick to condemn the study, the researchers noted that the study merely confirmed former research noting the drug increased risk of STDs. See the Reuters coverage: http://asia.reuters.com/newsArticle.jhtml?type=healthNews&storyID=2624281
Commenting Guidelines
LifeSiteNews welcomes thoughtful, respectful comments that add useful information or insights. Demeaning, hostile or propagandistic comments, and streams not related to the storyline, will be removed.
LSN commenting is not for frequent personal blogging, on-going debates or theological or other disputes between commenters.
Multiple comments from one person under a story are discouraged (suggested maximum of three). Capitalized sentences or comments will be removed (Internet shouting).
LifeSiteNews gives priority to pro-life, pro-family commenters and reserves the right to edit or remove comments.
Comments under LifeSiteNews stories do not necessarily represent the views of LifeSiteNews.